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Deaconess Medical Center, Boston, MA, and 5Harvard Medical School, Boston, 
MA, USA 
 
The neuropathology of Tourette Syndrome (TS) is poorly characterized. This 
thesis provides the first quantitative stereologic immunohistochemical study of 
the basal ganglia in TS. TS is a childhood neuropsychiatric disorder characterized 
by motor and vocal tics. Previous imaging studies found alterations in caudate 
(Cd) and putamen (Pt) volumes. To investigate possible alterations in cell 
populations, postmortem basal ganglia tissue from individuals with TS and 
normal controls (NC) was analyzed using unbiased stereological techniques. A 
markedly higher (>160% of control) total neuron number and density was found 
in the internal segment of the globus pallidus (GPi) of TS (p<0.025). An 
increased number (>220% of control) and proportion of these GPi neurons were 
positive for the calcium-binding protein parvalbumin (PV) in the tissue from TS 
subjects (p<0.025). In contrast, a lower number (<60% of control) of neurons 
was observed in the external segment (GPe) (p<0.025). In addition, there was a 
lower density of PV-positive interneurons in both Cd (<50% of control) and Pt 
iii 
(<65% of control) (p>0.025). The imbalance in striatal and GPi inhibitory neuron 
distribution suggests that the functional dynamics of cortico-striato-thalamic 
circuitry are fundamentally altered in severe, persistent TS.  
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– INTRODUCTION – 
A century ago, Ramon y Cajal described the state of central nervous system histology 
as “a number of unexplored continents and great stretches of unknown territory.”  One 
hundred years on, the neuropathology of neuropsychiatric diseases remains to be 
discovered.  While ‘purely’ neurological diseases have a rich history of neuropathological 
investigation, ‘purely’ psychiatric diseases do not.  Increasingly, the scientific consensus 
maintains that direct neurobiological investigation of psychiatric disease is necessary, 
though without neglecting important phenomenological work.  TS, because it comprises 
both neurological and psychiatric components, is an ideal disease to begin this project.  
Like many neuropsychiatric diseases, neither the etiology nor the pathophysiology of 
Tourette Syndrome (TS) is well understood.  A few models for the neural 
pathophysiology of TS exist, but these remain highly theoretical; while substantial 
clinical and imaging data exists for TS, the neuropathology of TS has rarely been 
investigated. To explore possible neuronal defects in TS, we undertook the first 
quantitative immunohistochemical study of TS.  
 
I. Clinical Features of Tourette Syndrome 
Tourette Syndrome (TS) is a childhood neuropsychiatric disorder characterized by 
persistent motor and vocal tics, affecting between 1 and 2% of children.1  Motor tics 
usually begin around age 5, while vocal tics begin around age 12.  Typically, tics occur in 
bouts, demonstrating a waxing and waning pattern of occurrence.  Tic severity, for most 
TS sufferers, peaks in adolescence.2  After this peak, tic symptoms variably decrease. 
However, in a distinct subset of patients, tics persist or reemerge in severe and 
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debilitating forms throughout adulthood.  One prospective study of 46 children (mean 
age of 11) found that 22% had significant symptoms approximately 7.5 years later.3  This 
was in accord with a previous survey showing that 28% of patients reported stable or 
worse symptoms 6 years later.4  The cause of persistent adult TS remains unknown, but 
it has been shown to be related to caudate size5, childhood tic severity3, and fine-motor 
deficits6.  
While popular imagination has seized upon coprolalia as a distinguishing feature of 
TS, only a minority of patients exhibits such symptoms.  Tics are repetitive, stereotyped 
motor movements that involve specific groups of muscles.  Tics are characterized by 
their anatomic location, number, frequency, duration, complexity and intensity.  Tics 
vary from simple (eye blinking or coughing) to complex (purposive appearing 
sequences, like brushing hair back or uttering phrases).  Tics also vary from in their 
intensity, from subtle to forceful.7  These factors are incorporated into rating scales used 
to assess and monitor TS severity.8  
TS encompasses a wide spectrum of phenomena.  Complex motor tics can sometimes 
be difficult to distinguish from other hyperkinetic movement disorders.  However, TS is 
not purely a movement disorder.  Tics are often preceded by sensory phenomena, akin 
to having an itch that can only be scratched by performing a tic.  This pattern of urge 
and response shares a phenomenological similarity with OCD, and, interestingly, TS is 
strongly co-morbid with obsessive-compulsive behaviors and obsessive-compulsive 
disorder.9  As such, TS is a quintessential neuropsychiatric disease, bridging movement 
disorders and anxiety disorders, and its study may shed light on a number of 
neuropsychiatric diseases. 
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II. The neurobiology of TS 
Both genetic and environmental factors are thought to contribute to the development 
of TS, but the exact role of each has not yet been identified.  Familial studies have 
documented vertical transmission, but no single major genetic vulnerability has been 
shown,* suggesting a genetic constellation for TS development.11  Epigenetic events that 
increase the risk of developing tic disorder or TS are generally pre- and perinatal 
adverse events, including toxin exposure and complications of parturition.  Most 
notably, perinatal hypoxic-ischemic events that damage the periventricular germinal 
matrix and adjacent deep regions of the brain increase rates of tic disorders.12  
A considerable amount of data implicates the cortico-striato-thalamo-cortical 
(CSTC) circuits in TS pathophysiology, particularly basal ganglia (BG) abnormalities.  
The BG, a richly interconnected set of nuclei, are essential for the initiation and correct 
implementation of learned sequences of motor and cognitive segments that characterize 
purposive behavior.  The BG appears to comprise several parallel circuits with distinct 
functions.13, 14  For each circuit, the two major inputs into the basal ganglia, from the 
cerebral cortex and the intralaminar nuclei of the thalamus, enter into the striatum, 
which consists of the caudate (Cd) and putamen (Pt). Schemata of BG tracts vary with 
the number of tracts; one common division maintains three distinct pathways: the 
sensorimotor circuit, the associative circuit, and the limbic circuit. The sensorimotor 
                                                 
* Recently, mutations of the SLITTRK1 gene, implicated in neurite outgrowth, has shown an 
association with TS. Study of 174 unrelated TS subjects showed 3 with SLITTRK1 mutations, 
suggesting both the importance of SLITTRK1 as well as underlining polyfactorial contributions 
to the disease.(10. Abelson JF, Kwan KY, O'Roak BJ, et al. Sequence variants in SLITRK1 are 
associated with Tourette's syndrome. Science 2005; 310:317-20.) 
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CTSC circuit begins in the sensory and premotor areas and synapses in the Pt posterior 
to the anterior commissure; the associative CTSC circuit begins in the various 
association cortices in the frontal, temporal and parietal lobes and synapses in the 
anterior third of the Pt and throughout the Cd; finally, the limbic CTSC circuit begins in 
limbic cortex, including the amygdala and hippocampus, and synapses in the ventral 
striatum, including the nucleus accumbens.  The rostral GP continues the associative 
circuit, the caudal GP the sensorimotor circuit, and the ventral GP the limbic.13 
The predominant cell type of the striatum is the GABAergic medium spiny neuron 
(MSN). MSNs, which are the large majority of neurons in the striatum, project to the 
globus pallidus pars interna (GPi), either directly or indirectly via the subthalamic 
nucleus and the globus pallidus pars externa (GPe) (See Figure 1).  These two pathways 
can be differentiated histologically: Substance P is contained within striatal terminals of 
the “direct pathway”, while met-enkephalin is contained within terminals of the 
“indirect pathway”. While this two pathway model is an extreme simplification, it has 
been useful in modeling other diseases of the BG, for example, Parkinson’s.  
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Figure 1.  A schematic of the cortico-striato-thalamo-cortical loop.  
Within the basal ganglia, two main pathways are thought to exist: the direct pathway, which 
runs from the striatum to the GPi /SNr to the thalamus, and the indirect pathway, which runs 
from the striatum to the GPe to the STN to the GPi/SNr.  Within the striatum are PV+ 
interneurons, which appear to modulate striatal input and output. SN = substantia nigra; GPe = 
globus pallidus externa; GPi/SNr = globus pallidus interna/substantia nigra reticulata; STN = 
subthalamic nucleus. 
 
MSNs form approximately 80% of the cells of the striatum, with interneurons 
accounting for the remainder.15 There are four types of interneurons in the striatum: 
parvalbumin-positive (PV+), cholinergic (ACh), somatostatin/NPH-positive and 
calretinin-positive. These interneurons, except the ACh cells, are GABAergic. The 
functions of the calretinin-positive and NPH-positive cells are poorly understood, but 
the other cell types have been characterized. ACh interneurons receive input from 
thalamic nuclei, and synapse on the PV+ interneurons as well as the MSNs (See Figure 
2). ACh cells are also called tonically-active neurons (TANs), and appear to play a role in 
regulating the response to reward-related stimuli.15, 16 They are capable of both de- and 
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hyperpolarizing PV+ interneurons, and may be important in allowing local disinhibition 
of MSNs by curbing PV+ activity.17 
The firing of cortical inputs drives activity in both medium spiny neurons (MSN)18 
and parvalbumin-positive (PV+) GABAergic interneurons.19 Striatal PV+ interneurons 
are electrically coupled by gap junctions, forming a web of inhibitory synapses 
throughout the striatum.20 The PV+ cells synapse on the somata of the MSNs, and 
electrophysiological studies demonstrate powerful inhibition and coordination of the 
activities of MSNs, likely altering the response to cortical inputs21-24. (See Figure 2) 
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Figure 2. A schematic of inputs to the striatum and intrastriatal connections emphasizing 
parvalbumin neurons.   
Parvalbumin positive neurons receive input from cortex and cholinergic neurons. Parvalbumin 
cells form an electrotonic network in the striatum. The parvalbumin network exhibits strong 
control over MSN firing, maintaining tonic inhibition of MSN activity. Local cholinergic input 
may inhibit a section of the PV+ network to allow MSN firing.  MSNs = medium spiny neurons. 
While a great deal of evidence implicates the striatum in in TS pathology, our data provide 
evidence for a specific class of cells which may be defective in TS.  Studies of these cells suggest 
that a defect in their function would be consistent with TS phenomenology. In particular, PV+ 
cells appear to integrate sensory and motor cortical inputs, regulate oscillation frequency, 
maintain the low rate of MSN baseline activity, and decrease desynchronous (‘noise’) firing from 
cortical inputs. 
 
Cholinergic neurons
Thalamus 
Parvalbumin neuron network
Cortex
MSNs 
Striatum 
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The GPi appears to provide the major output of the BG in humans.25 The GP contains a 
high percentage of PV+ neurons: approximately 75% of GPi and 50% of GPe cells are 
positive for this calcium-binding protein.26 However, unlike those in the striatum, PV+ 
cells in the GPi are projection neurons. The GPi inhibitory projections to the thalamus 
have a major influence on the firing rate and rhythmic activity of both ventrolateral and 
intralaminar thalamic nuclei,27 which, then project back to the various origins in 
sensorimotor, associative or limbic cortex. 
Each of these channels (sensorimotor, associative and limbic) forms a discrete 
pathway, and therefore, the possibility of specific phenomenological consequence when 
lesioned.  Given the wide spectrum of phenomena in TS, it is not surprising that many 
major structures of the basal ganglia have been implicated in TS.  Chemical and 
electrical stimulation of the Pt in both animals and humans can produce tic-like 
stereotypies.28 Structural imaging studies have consistently shown small but significant 
decreases in Cd and Pt volumes in TS,29 while functional imaging has shown decreased 
activity in the ventral striatum.30-32  Treatment of TS pharmacologically involves 
dopamine and serotonin modulating agents, and as such alterations of these 
neurotransmitters might reasonably be thought to be involved in TS pathophysiology. 
While serotonin in TS has not been adequately studied, metabolic studies of dopamine 
terminals have suggested increased densities.33  Additionally, levels of neuronal activity 
as measured by fMRI while patients are asked to actively suppress their tics are related 
in a complex manner to tic severity outside the magnet, such that neuronal activity in 
the head of the right Cd is inversely correlated with tic severity, whereas neuronal 
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activity in the GP and Pt is directly correlated with tic severity.34  Intriguingly, 
therapeutic use of deep brain stimulation in TS generally targets the parafascicular and 
centromedian nuclei of the thalamus, which synapse on the ACh cells of the striatum, 
further implicating this circuitry in TS. 35-46 
These data, taken together, suggest strongly that the BG, particularly the striatum, 
are the primary location of TS pathology.  Two general models of BG function and TS 
pathophysiology currently exist.  The classical model, also known as the rate model, 
maintains that the primary function of excitation and inhibition is to alter the rate of 
firing of downstream neurons: inhibition acts as a ‘brake’ on neuronal activity.  
Neuronal activity, in this model, functions as an analog property.47  An increase in 
activity of inhibitory neurons decreases the rate of firing of the neurons on which they 
synapse.  This model, in which the indirect pathway is seen as opposed to the direct 
pathway, has offered a productive model of some movement disorders, where increases 
in direct pathway activity or decreases in indirect activity leads to hyperkinesis and, 
conversely, decreases in direct pathway activity or increases in indirect pathway activity 
lead to hypokinesis.  
An alternative, emerging theory of BG function takes a state-dependant approach, 
classifying neuron activity according to varied frequencies: delta (< 2 Hz), theta (~2-7 
Hz), alpha (~8-12 Hz), beta (~15-30 Hz) and gamma (30-80 Hz).48-51  Synchrony at 
particular frequencies, and local areas of desynchrony, represent different states of 
functioning and information representation by, for example, modulating synaptic 
plasticity.52, 53  In this model, the size of the neuronal population entrained is inversely 
related to oscillation frequency.  PV+ interneurons are essential components in this 
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model.  These cells, connected by gap junctions, are remarkable for their ability to fire at 
extremely high frequencies with little adaptation, narrow action potentials (APs) and 
rapid large-amplitude afterhyperpolarizations (AHPs)23, 54, 55.  These properties are 
thought to be facilitated by PV, a calcium binding protein that may act as a calcium 
reserve in the cytoplasm of the cell.  They synapse directly on the somata of MSNs, 
allowing strong control of MSN function56. Gap junctions, combined with the 
electrophysiologic properties of PV+ interneurons, allow regulation of 
electrophysiologic oscillations; additionally the PV+ neuron network, by receiving 
multiple cortical inputs, may act as a coincidence detector,57 and through lateral 
inhibition of desynchronized cortical input, may increase signal fidelity and modulating 
through-put57-61. Evidence suggests these cells play this role not only in the BG, but in 
cortex as well.61 
 Defects in PV+ cells have the potential to form part of the pathophysiology of 
many neuropsychiatric diseases.  In this paper, we investigate the possibility that defects 
in PV+ cells in the basal ganglia may form part of the neurohistological phenotype of TS. 
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–  STATEMENT OF PURPOSE – 
In an effort to better understand the cellular abnormalities that may be present in 
TS, we undertook the first quantitative postmortem study of the basal ganglia of 
individuals with TS as compared to age- and sex-matched normal controls (NCs), 
staining with cresyl violet, parvalbumin, met-enkephalin, and substance P.  
Our hypothesis was as follows: TS may demonstrate histological abnormalities in the 
basal ganglia of the following kinds: 
- a defect within the indirect pathway, in cell number, morphology or density, 
consistent with an impairment of inhibition of thalamocortical signaling  
- an abnormality within the direct pathway, in cell number, morphology or density, 
consistent with hyperactivation of thalamocortical pathways 
- an alteration in cell number, morphology or density of parvalbumin cells within 
the striatum, consistent with impaired cortical signal gating or oscillatory 
regulation 
- an alteration in cell number, morphology or density of parvalbumin cells within 
the globus pallidus, consistent with impaired thalamic inhibition or altered 
oscillatory production 
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– METHODS – 
Subjects.  
A cohort of human brains obtained from the Harvard Brain Tissue Resource Center 
at McLean Hospital and the Yale Department of Critical Technologies was used in this 
study and included 5 normal controls (mean age, 60 ± 9.7) and 3 subjects with severe, 
persistent TS (mean age, 42 ± 11.9) (See Table 1).  Normal control (NC) subjects were 
collected after routine autopsy at Yale University and Massachusetts General Hospital. 
The TS specimens were obtained following informed consent from the next-of-kin, and 
donated brain tissue was collected under the sponsorship of the Tourette Syndrome 
Association (TSA) tissue resource.   This group of TS subjects was selected from a larger 
group of donated specimens (N=41).  Reasons for exclusion included the presence of a 
neurological condition that might limit the interpretation of the findings, e.g., 
Alzheimer’s disease, brain tumors, problematic agonal events (such as a prolonged 
interval on a respirator before death), or an excessive post mortem interval (N=17); an 
inability to locate the next-of-kin (N=5); the presence of a significant, severe comorbid 
psychiatric disorder, e.g., schizophrenia, bipolar disorder (N=8); or insufficient or 
improperly processed tissue (N=8).  Tissue sections from one hemisphere were 
examined by routine neuropathological tests, and all TS or NC brains with any evidence 
of gross pathological changes or CNS cytological abnormalities, including cellular 
ischemic changes were excluded from analyses.  
Each of the TS subjects was matched with one or more normal control subjects on 
the basis of age, postmortem interval, and, whenever possible, hemisphere (i.e., right vs 
left). All of subjects in this study were male.  
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Table 1. Subjects  
 
Subject # Stained with Age, y Sex PMI Cause of Death 
YA99-7 (R) CV 56 M 18 Peritonitis 
Hcon (R) CV, PV 47 M 21 Myocardial infarct 
M96021 (L) CV 65 M 8.5 Sepsis 
Y98209 (R) PV 59 M 20 COPD 
Y98183 (R) PV 73 M 12 Aortic dissection 
Average  60 M 16  
 
TS Case # Stained with Age Sex PMI Mode of Death 
4187 (L, R) CV, PV 54 M 11 Myocardial infarct 
4454 (L, R) CV, PV 37 M 27 Accidental 
overdose 
4790 (L) CV, PV 34 M 30 Myocardial infarct 
Average  42 M 23  
 
Table 1. Basic subject data from which histological sections were obtained.   
PMI= postmortem interval in hours. Differences in age and PMI were not significant by 
nonparametric statistics. Due to limitations of tissue supply, not all control brains could be 
evaluated for both total cell number by cresyl violet (CV) and PV+ cell density. 
 
Psychiatric diagnoses were established using a retrospective review of medical records 
and an extensive family questionnaire that included the medical, psychiatric, and social 
history of the subjects.  For the diagnosis of TS, Attention Deficit Hyperactivity Disorder 
(ADHD), obsessive-compulsive disorder, major depressive disorder, alcohol or drug 
dependence DSM-IV criteria were used.  A best estimate procedure was used once all 
available data had been compiled (JFL, HG).62 The TS diagnostic confidence index was 
also estimated.63  All TS subjects had a “definite” DSMIV diagnosis of TS. They also had 
TS diagnostic confidence index Scores of >90, as well as a history of severe tic symptom 
severity, scoring 49-50 out of 50 points on the Yale Global Tic Severity Scale at the 
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“worst ever” point in their lives (See Table 2).8  Two cases were associated with a 
positive family history for TS or chronic tics, and the third case with a history of 
perinatal hypoxia.  One of the three TS subjects (case 4454) was not taking antipsychotic 
medications at the time of death.  The other two subjects were on a variety of 
medications (Table 2).  No subject in the NC group was receiving any psychotropic 
agents at the time of death.  
 
Immunocytochemistry. 
Intact half brains were stored in 10% formalin.  The telencephalon and brainstem 
were cut coronally into 2.5 cm blocks, labeled A, B, C, D and E, from anterior to 
posterior.  Blocks were rinsed in phosphate-buffered saline/0.1% NaN3 (PBS/azide) and 
cryoprotected in 15% sucrose.  Tissue was serially sectioned at 50 µm using a cryostat or 
a freezing microtome and 24 series of sections were collected.  
Sections were rinsed 3 times in PBS, and endogenous peroxidase was quenched by 
incubation in 3% H2O2 for 30 min at room temperature.  Sections were blocked in PBS 
containing 5% normal horse or goat serum and 0.1% Triton-X-100 (PBS-serum) for 30 
min at room temperature and then incubated with the first antibody for 48 h at 4ºC in 
PBS-serum.  Primary antibodies were anti-parvalbumin (1:2500; Sigma, Saint Louis, 
MI); anti-substance P (1:1000; Immunostar, Hudson, WI) and anti-metenkephalin 
(1:1000; Immunostar).  After 3 washes in PBS, sections were incubated with 
biotinylated secondary antibodies (Vectastain Elite kit, Vector, Burlingame, VT) in PBS-
serum, and processed for immunoperoxidase staining according to manufacturer’s 
instructions.  
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Table 2. Characteristics of the TS subjects  
Age 56 37 34 
MOD Myocardial 
infarct 
Overdose of lithium, 
Clonazepam, OTC 
sedatives and 
stimulants 
Probable myocardial 
infarct 
DCI (0-100) 95 95 95 
Age of onset  7.5 7.5 ND 
YGTSS TIC WE 
(0-50) 
49 50 
WE at age 13 yrs 
49 
WE at age 30 
Family history Positive, 
multiple cases 
Positive, a paternal 
grandfather 
Negative 
Developmental 
History* 
No evidence of 
any difficulties 
One febrile seizure 
at 18 mos; possible 
streptococcus 
infection 
Perinatal hypoxia & 
prolonged labor 
Problematic 
agonal history 
Resuscitation 
efforts  
None None 
Medications Olanazapine 5 
mg; 
Clonazepam 0.5 
mg; Fluoxetine 
30 mg 
Prescription and 
OTC sedatives; 
Haloperidol, 
Pimozide, Clonidine 
and guanfacine in 
the past 
Zisprasidone for 10 
months prior to 
death; Clonazepam 
for 3 yrs; Pimozide for 
10 yrs. Risperidone 
for 1 yr; Clonidine as a 
child 
 
Table 2. Characteristics of TS subjects. 
All cases ranked 95 in terms of certainty of TS diagnosis using the DCI (Diagnostic confidence 
index), a scale that measures the lifetime likelihood of having or of have ever had TS 63. MOD= 
mode of death. YGTSS TIC WE= Worst ever Yale Global Tic Severity Scale 62.  ND =not 
determined. OTC= Over the counter 
*Possibility that there may have been an injury to the brain early in development 
Tissue from control and TS was processed concurrently and exposed to the substrate for 
exactly equal amounts of time.  
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Of the above, the cresyl violet staining, anti-metenkephalin and anti-substance P 
staining was performed by WZ and FV. WZ, FV and I performed the parvalbumin 
staining. WZ and FV performed most of the PV staining of blocks containing GP 
sections; of these I stained 2/9. I performed the PV staining of all (6/6) the sections 
containing Cd and Pt without GP (the anterior and posterior blocks).† 
 
Stereological Analyses.  
One series of sections, 1.2 mm apart, was stained with cresyl violet and subjected to 
unbiased stereological analysis using a Zeiss Axioskop 2 mot equipped with an 
automatic stage and coupled to a computer running StereoInvestigator and Neurolucida 
software. The Cd, Pt, GPe and GPi regions were drawn in each section in the series 
based on cytoarchitectonic landmarks. When applicable, the volume of these nuclei was 
estimated by planimetry, which is computed by adding up the cross-sectional areas of 
the nucleus of interest in each section and by multiplying this number by the section 
interval and by the average section thickness (measured at the time of counting).  
 Nuclear profiles were counted using the optical fractionator method with a 40X oil-
immersion objective, by randomly placing a sampling grid over each contour. Sampling 
grids measured 1800 x 1800 µm for GPi and 1500 x 1500 µm for GPe. Tri-dimensional 
counting frames (180 x 180 x 15 µm for GPi and 130 x 130 x 15 µm for GPe) with 3 out of 
6 exclusion borders65, 66 were automatically placed by StereoInvestigator at each grid 
                                                 
† This applies to the data presented in this thesis and the resultant publication 
(64. Kalanithi PS, Zheng W, Kataoka Y, et al. Altered parvalbumin-positive neuron 
distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A 
2005; 102:13307-12.). YK has continued this work; her additional data is discussed in footnotes. 
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intersection point.  Approximately 412 frames were sampled in the GPe and 124 frames 
in the GPi.  On average, 280 neurons per brain were counted in the GPe, and 81 in the 
GPi.  Neurons and glia were separately counted in each frame, distinguished on the 
basis of their cytological appearance.  The total number of cells per region was 
calculated by StereoInvestigator using the formula  
N= ∑Q ∗ t/h∗1/asf ∗1/ssf 
 where ∑Q was the total number of nuclei counted, t the mean section thickness, h 
the height of the optical dissector, asf is the area sampling fraction, and ssf is the section 
sampling fraction.66  The density for each cell type was calculated by dividing the total 
number of cells by the total counting volume.  
For the parvalbumin-stained sections, the protocol was identical to the above, except 
for the sizes of the sampling grids and counting frames.  Sampling grid in the GP 
measured 1000 x 1000 µm, counting frames measured 130 x 130 x 15 µm.  In the 
striatum the sampling grid measured 2500 x 2500 µm, and counting frame measured 
700 x 500 x 15 µm.  The counting frames were placed in the most superficial portion of 
the sections (1 µm from the surface), to avoid variability due to differential penetration 
of antibodies.  Cell density within tissue was calculated by dividing the total number of 
cells by the total volume of tissue sampled.  Approximately 356 frames were sampled in 
the Cd, 417 in the Pt, 368 frames in the GPe and 327 frames in the GPi.  On average, a 
total of 244 cells per brain were counted in the Cd, 348 in the Pt, 172 in the GPe, and 
244 in the GPi. 
I performed the majority of the stereological counts, including counting almost all 
the PV immunostained sections presented here; of note, I recounted a significant 
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portion of the work performed by the other counters (WZ and YK), and the inter-person 
count variability was less than 3%.  Additionally, I performed stereological counts and 
partial analysis of 12 blocks of insular cortex, which was aborted in order to focus purely 
on BG structures.   Finally, using the Stereoinvestigator software and Excel, I performed 
all the quantitative analysis discussed in the Results and Discussion sections.  Statistics 
were performed by MS. 
 19
 
– RESULTS – 
I. Cresyl violet staining 
CV staining is nonspecific, allowing assessment of neurons as well as glia, which can 
be distinguished by size.  All brains from the TS cases showed an increase in both 
density and total neuron number in the GPi as compared to NC (See Table 3).  These 
changes were remarkably consistent in our sample, such that the differences in total 
neuron number in the GPe and GPi between NC and TS were statistically significant 
despite the small number of patients. 
No change in size or shape of the neuronal cell bodies was noted.  The total number, 
density and morphology of glial cells did not differ among TS or control brains in either 
the GPe or GPi.  No differences in the volume of the GPe or the GPi were detected 
among the subjects (See Table 3).  
Table 3. Differences in total cell number in the Basal Ganglia of NC and TS  
  Volume 
(mm3) 
Tot. Neuron 
No. (x 103) 
Neuron density 
(103 cells/mm3) 
Total glial 
No. (x106) 
Glial density 
(103 cells/mm3) 
GPe NC 491.4 ± 
41.1 1695 ± 304 3.41 ± 0.36 177 ± 21.4 372 ± 74.6 
 TS 442.4 ± 
10.5 910 ± 105* 2.05 ± 0.20* 158 ± 6.2 358 ± 17.6 
GPi NC 223.2 ± 
32.8 540 ± 49 2.54 ± 0.46 
 
63.5 ± 2.1 
 
297 ± 42.5 
 TS 230.0 ± 
25.7 905 ± 108 * 4.00 ± 0.54 
 
72.4 ± 9.1 
 
319 ± 39.4 
 
Table 3. Morphometric analysis of globus pallidus subregions after cresyl violet staining in NC 
and TS patients. Values represent group means ± SEM. The volume, total cell number and 
density was assessed in serial sections by stereological analyses using StereoInvestigator, as 
described in the text.  
* TS versus NC statistically different; p<0.025, Mann-Whitney U test. 
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 Table 4 Density (cells x 1000/ mm3 ± SEM) 
  NC TS TS/NC (%) 
Cd (head) 41.1 ± 6.7 40.2 ± 2.6 -2.2 
Cd (body) 57.1 ± 4.4 41.3 ± 2.6* -27.6 
Pt 42.5 ± 4.0 36.0 ± 2.6 -15.0 
 
Table 4. Cell density of striatal subregions after cresyl violet staining in NC and TS subjects. 
Values represent group means ± SEM. Cell density includes measurements of MSNs, glia and 
interneurons. The volume, total cell number and density was assessed in serial sections by 
stereological analyses using StereoInvestigator, as described in the text.  
* TS versus NC statistically different; p<0.025, Mann-Whitney U test. 
 
 Cresyl violet staining of the striatum revealed a general decrease in cells in the 
body of the Cd: TS subjects appeared to have 28% fewer cells.  In the Cd head and the 
Pt, no significant difference in cell density was detected (See Table 4).  No 
morphological differences were noted between the cells of TS and NC subjects. 
 
II. Parvalbumin staining 
We immunostained sections for parvalbumin (PV), which is normally expressed by 
the majority of GP cells and assessed the density of these cells in various regions of the 
basal ganglia by unbiased sampling methods.  The density of PV+ cells was higher by 
122% in the GPi of the subjects with TS as compared to NC.  In contrast, the brains from 
TS subjects exhibited a lower density of PV+ neurons in all other basal ganglia regions 
assessed.  This difference was strongest in the Cd (51% lower), smaller in the Pt (37%), 
and the smallest in the GPe (23%) (See Figure 3).  
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Figure 3. Unbiased estimates of PV cell density in three TS and three NC brains. 
 Each small square represents a single subject. Cd, Caudate; Pt, Putamen; C, GPe, Globus 
Pallidus Pars externa; D, GPi, Globus Pallidus Pars interna. Differences in PV neuronal density 
in the Cd, Pt, and GPi of TS patients were statistically significant (p<0.025, Mann Whitney U 
test). 
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PV+ cells in both pallidal regions are large, multipolar projection neurons.  This 
morphology did not appear to differ in the brains of TS subjects (See Figure 4).  In the 
striatum, in contrast, PV+ cells are much smaller and display an extensive 
dendritic/axonal tree.  Again, no apparent difference in PV cell morphology was present 
in the Cd and Pt of brains of TS cases as compared to NCs (see Figures 5, 6).  The 
density of PV immunoreactivity in the neuropil (presumably reflecting the dendrites and 
axons of these cells) was clearly decreased in the Cd and Pt of TS cases as compared to 
corresponding regions of NCs (See Figure 5). 
To estimate the total number of PV+ cells, we multiplied the PV+ cell density in the 
GPi and GPe of each subject by the corresponding volumes (See Table 4).  The results 
suggest that the number of PV+ neurons was 30.8% smaller in the GPe of patients with 
TS, while it was 129% larger in the GPi of patients with TS in comparison to NC.  These 
changes are virtually identical to those noted for PV+ neuron density in these regions, as 
total volumes were not significantly different between the groups.  For the Pt and the 
Cd, we could not obtain total volumes by stereological analyses with the available tissue. 
To have an estimate of total number of PV+ neurons in these regions for comparison to 
the GP data, we used an extensive neuroimaging dataset of 130 NCs and 154 TS 
subjects29 and used their average Cd and Pt volumes after correcting for shrinkage due 
to tissue processing (see Table 4 legend).  
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Figure 4. Sections of GPi. 
Increase in number of PV-containing neurons in the GPi of TS patients. A,B: PV immunostaining; C,D: 
cresyl violet staining. Representative sections from the GPi of NC (A,C) and TS (B,D) are shown. The 
morphology of the GPi neurons appears the same between TS and control. V=vein. Arrows indicate 
projection neurons. Scale bar, 100 µm. 
A. Control tissue B. TS brain 
C. Control tissue D. TS brain 
Parvalbumin stained sections of the GPi 
Cresyl violet stained sections of the GPi 
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Figure 5. Parvalbumin stained sections of the caudate. 
Arrows indicate PV+ fast-spiking GABAergic interneurons.  
Parvalbumin staining of the Cd 
A. Normal control 
B. TS 
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Figure 6.  Parvalbumin staining in the Putamen. 
The morphology of the cells does not appear to differ between TS and control. 
A. Normal 
control 
B. TS 
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Table 5. Number of parvalbumin neurons 
in TS 
 Total PV cell number 
 NC TS Difference (%) 
Cd 572,000 266,000 -53.5 
Pt 548,000 333,000 -39.3 
GPe 1,020,000 707,000 -30.8 
GPi 369,000 846,000 +129 
Total 2,509,000 2,152,000 -14.2 
 
Table 5. Calculated number of PV neurons in TS. To derive total cells, we multiplied 
our average PV density for the average volume obtained after tissue processing (Table 3). For 
the Cd and Pt, we used published in vivo volumetric data29, which were first corrected according 
to a shrinkage factor of 0.40%. The shrinkage factor was obtained by dividing our GP volume 
(the sum of GPe and GPi calculated by stereological analyses after tissue processing) to that of 
Peterson et al29.  Virtually identical volumes were obtained for the combined GP (GPe and GPi) 
applying the neuroimaging dataset after shrinkage correction and stereology (715 and 672 for 
NC and TS subjects, respectively, using stereology; and 712 and 674 NC and TS subjects, 
respectively, using neuroimaging after correction). 
 
The results, reported in Table 5, suggest that the number of PV+ neurons was 53.5% 
and 39.3% smaller in the Cd and Pt, respectively, of patients with TS in comparison to 
NC.  These changes in total PV+ cell number between NC and TS individuals are again 
similar to those reported in Figure 1 for PV+ cell density.  Interestingly, the total 
number of PV+ neurons in the basal ganglia was decreased in TS by only 14.0% (p> 
0.025, not statistically significant), suggesting that this group of TS patients differ with 
respect to the NC with respect to the distribution of PV neurons, and indicate the 
possibility that the overall number of PV neurons in the basal ganglia remains 
unchanged. (See Figure 8, in the Discussion.) However, given the small sample size, no 
firm conclusion regarding total numbers of PV cells can be drawn. 
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By subtracting the total parvalbumin neuron number from the total neuron number, 
we estimated changes in parvalbumin-negative neurons.  However, we did directly 
assess PV-negative cells; thus these numbers are only estimates.  The GPi of cases with 
TS appeared to have substantially fewer parvalbumin-negative cells: the GPi of control 
brains had 1.7 x 105 parvalbumin-negative neurons, while the GPi from subjects with TS 
had less than half that number, 7.0 x 104. In the GPe of the subjects with TS there were 
also fewer parvalbumin-negative neurons, 2.0 x 105 compared to 6.7 x 105. The 
differences were roughly similar, of 59% in the GPi and 69% in the GPe. 
A post-hoc analysis of this data was performed to examine whether the changes in 
density varied by location within the BG subregions examined. Following prior studies 
of PV distribution,67 the Pt, GPe and GPi were separated into rostral and caudal 
segments at the anterior commissure.  
 rGPi  cGPi rGPe cGPe rPt cPt 
Control (x1000/mm3) 21.6 15.2 23.5 17.2 2.79 2.59 
TS 
(x1000/mm3) 37.4 34.8 14.1 17.3 2.41 1.65 
% Change 73.23 128.99 -40.01 0.14 -13.44 -36.17 
 
Table 6. Post-hoc analysis of data examining rostral-caudal differences. 
Increases in the GPi are large throughout, but more pronounced in caudal regions. Within the 
GPe, decreases appear to be solely within the rostral component. In the Pt, differences appear to 
be more caudal than rostral. (rGPi=rostral globus pallidus interna, cGPi=caudal globus pallidus 
interna; rGPe=rostral globus pallidus externa; cGPe=caudal globus pallidus externa; rPt=rostral 
putamen; cPt=caudal putamen)  
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III. Substance P and met-enkephalin staining 
 
To assess whether functional neurotransmitter abnormalities may be present in TS, 
we performed immunostaining for substance P (SP) and met-enkephalin (enk), 
neuropeptides contained within striatal MSN of the direct and indirect pathways, 
respectively. Consistent with previous data,68 SP-positive “woolly fibers” were 
concentrated in the GPi, suggesting that they represented terminals of the direct 
pathway; in contrast, enk-positive “woolly fibers” were greatly enriched in the GPe 
although a subset reached the GPi, consistent with being terminals of the indirect 
pathway.  No qualitative difference in staining intensity within individual “woolly fibers” 
between cases and controls was apparent.  A close comparison of sections for the TS and 
NC cases under examination showed no differences in the apparent density or 
distribution of fibers immunoreactive for these neuropeptides between NC and cases of 
TS (See Figure 7). 
 
IV. Demographic data  
No correlation was found between changes in PV or CV cell densities and neuroleptic 
intake or postmortem interval. While TS patients had co-morbid diagnoses, TS was the 
only diagnosis in common among them. Two patients had positive family histories of 
TS, and one had a perinatal hypoxic event; no obvious correlation existed between 
morphometric changes and suspected etiology. One control and one TS brain were at 
risk for secondary complications due to the agonal history (See Tables 1 and 2); 
however, no obvious correlations were found between this history and PV+ neuron 
number or density.
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Figure 7. Met-enkephalin and Substance P Staining. 
 
Staining for the MSN projections in the indirect (met-enkephalin) and direct (substance P) pathways revealed 
no apparent difference in morphology or density. 
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– DISCUSSION – 
 
The data presented above provide the first quantitative cellular characterization of 
specific cell types within the basal ganglia of subjects with severe and persistent TS.  Our 
data demonstrate a consistent and profound PV+ neuronal imbalance in the basal 
ganglia of the three patients examined.  The striatum had fewer PV+ neurons, while the 
GPi had substantially more.  These changes in the PV+ neuron distribution partially 
account for changes in the total neuron number in the GP subregions, which occurred in 
the absence of any change in volume or in glial cells.  Using unbiased sampling methods, 
54% and 35% decreases in PV neuron density were detected in the Cd and in Pt, 
respectively, of TS patients.  The decrease in PV+ neurons in the Cd is consistent with 
the small (<5%) decreases in Cd volume which is present in both children and adults 
with TS,69 a decrease that in children is also correlated with tic severity later in life.5 
Confirming earlier studies in TS,70 no changes were detected in the apparent density of 
MSN projections in either the SP-immunoreactive direct or the enk-positive indirect 
pathways.  However, we must await unbiased estimations of the total number of MSN 
using appropriate markers to definitively settle the question of whether MSN are altered 
in TS.   
Taking the basal ganglia as a whole, there is a small (14%) non-significant decrease 
in PV+ neurons in TS (Table 5), while the distribution of PV cells is strikingly altered in 
TS, with far more PV+ cells in the GPi and substantially fewer in other regions of the 
BG, particularly the Cd.  We think that it is unlikely that the above changes in PV+ 
neuron distribution are due to altered PV expression, for two reasons.  First, the PV+ 
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cell changes in the GPi are paralleled by changes in total neuron number, as assessed by 
cresyl violet staining; and second, it is improbable that variables that might affect the 
expression or the immunodetection of PV would manifest in opposite ways among basal 
ganglia subregions.  For example, the increase in cresyl violet-stained neurons in the 
GPi from subjects with TS is fully accounted for by the increase in PV+ cells in this 
nucleus.  Remarkably, both density and number of PV+ neurons were more than twice 
as large in TS as compared to NC.  However, parvalbumin expression has been shown to 
be sensitive to neurotransmitter changes, such as those elicited by cocaine exposure,71 
and we cannot completely rule out that complex changes in both number of neurons and 
PV expression occur in TS.  
Our data also suggest that other neuronal populations besides PV neurons may be 
affected in TS, because a 46.2% statistically significant decrease in total neuron number 
was observed in the GPe, whereas the density or number of PV+ cells is decreased on 
average by only 30% in this region (this decrease is not statistically significant, which 
may be a reflection of the small number of subjects).  Similarly, our data may be 
interpreted to suggest a decrease in non-PV+ neurons in the GPi from subjects with TS, 
because the proportion of PV+ is much higher in the GPi of TS patients.  These data 
suggest a possibility that parallel, opposite changes may be occurring in a PV-negative 
population of cells in the GPi in this disorder.  The nature of these PV-negative neurons 
is currently under investigation.  They appear to have a slightly different morphology as 
PV+ neurons72 and location within the GPi73 and some evidence suggests GP PV+ 
neurons primarily provide the BG output, as opposed to forming intra-BG 
connections.74  While parvalbumin’s calcium binding ability has been hypothesized to 
affect refractory hyperpolarization, and therefore, firing frequency,75 whether there are 
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any functional differences between PV-positive and PV-negative neurons in the GP is 
currently unclear.  Given that we did not specifically investigate PV-negative cells, 
further research examining these populations would have to be conducted to 
characterize these populations. 
The data presented here have additional limitations.  The small sample size may not 
be representative.  However, the consistency of the results engendered statistical 
significance by non-parametric analysis.‡  While TS is a neurodevelopmental disorder, 
our subjects, by necessity, were adults.  This complicates the data in three ways.  First, 
adult cases of TS may represent an atypical form of TS.  Classical forms of TS may differ 
in the natural history and severity from adult TS.  Classical TS usually peaks in 
adolescence with symptoms easing into adulthood, whereas adult TS persists and tends 
to be far more severe.  Our subjects presented with extreme forms of TS, with almost 
maximum scores on TS rating scales.  While studying extreme presentations of 
pathology has a long history of revealing mechanisms of more benign forms of disease, 
we cannot rule out that adult severe TS represents a separate disease with a distinct 
neural presentation.  Second, the blocks of tissue available to us did not include certain 
portions of the basal ganglia circuit, including the SNr (which, however, may be a less 
important structure than the GPi in humans25) and STN.  Moreover, we did not have 
access to other portions of the CTSC, including relevant areas of the cortex and 
thalamus.  As such, we cannot rule out separate pathologies of these areas.  However, 
while clinical and experimental data suggests that the thalamus and particularly areas of 
cortex may play an important role in TS, the BG, in particular the striatum, remain the 
                                                 
‡ Further, additions of new TS brains analyzed by YK since the generation of the data 
discussed here have confirmed the initial results. 
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predominant area of interest.  We only examined PV+ cell populations, but other 
interneuron populations may be affected as well.§  Additionally, while the statistically 
significant positive findings of the study suggest real differences, the small number of 
subjects precludes confidence in negative results.  As such, other abnormalities in cell 
numbers may exist.  Finally, our study shares the limitations of all neuropathologic 
studies.  Based on purely immunohistochemical data, physiological conclusions cannot 
be firmly drawn. We cannot assert that our findings represent the original insult in TS 
nor can we rule out the possibility that our findings represent compensatory changes to 
a different pathology, or changes secondary to other phenomena, for example, 
medications taken.  However, by attempting to locate our findings in the context of 
current and emerging understandings of basal ganglia function and dysfunction, the 
data are placed in their most likely context, and most importantly, testable hypotheses 
may be generated to confirm the theories of pathophysiology and etiology. 
The PV+ neuron deficit in the TS striatum fits both traditional circuit-based models of 
basal ganglia pathophysiology47, 76-79 as well as emerging oscillation models49, 50.  In the 
traditional circuit, cortical input excites PV+ interneurons80 which, in turn, powerfully 
inhibit MSNs23, maintaining the characteristic low activity of the striatum.  The loss of 
PV+ interneurons in this circuit would thus disinhibit MSNs, which should lead to MSN 
hyperactivity, GPi hypoactivity and increased thalamocortical firing, producing a 
hyperkinetic state.79  Consistent with this hypothesis, as noted above, microstimulation of 
the Pt produces stereotypies, suggesting that local hyperactivity of MSNs can produce 
tics. 
                                                 
§ YK has performed an analysis of calretinin-positive cells, and initial data suggests that 
a subpopulation of them, likely identical to ACh interneurons, are decreased in density 
in TS in the Cd head by 64%. 
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The loss of PV+ interneurons leading to tics is also consistent with oscillatory 
models of BG function.  Recent recordings from monkeys indicate that, when still, striatal 
activity is synchronized at a beta-band oscillatory frequency (15-30 Hz); during 
movement, certain localized striatal sites desynchronize, resynchronizing after the 
movement ceases.81  PV activity may limit the spread and therefore the spatial extent of 
the striatal desychronization elicited by cortical inputs.  Other in vivo recordings suggest 
that, at rest, high amplitude spindle and theta-band (~8 Hz) oscillatory frequencies are 
prominent in the striatum of awake rats.20  Because PV+ striatal interneurons form an 
electrically coupled inhibitory network that can entrain very large assemblies of 
neurons,19, 23, 24 the PV+ interneuron network may play a critical role in the synchrony of 
striatal oscillations and their modulation by the cerebral cortex and thalamus.20   Hence a 
deficit in striatal PV+ interneurons may plausibly impair the PV+ interneuron network’s 
ability to maintain synchrony, leading to inefficient production of oscillatory frequencies 
and inappropriate desynchrony of small populations of striatal MSN, resulting in tic-like 
behavior.  
The potential role of PV+ interneuron deficits in promoting tic-like behavior finds 
confirmation in a hamster model of idiopathic paroxysmal dystonia.  The dtsz hamster 
phenotype shares many features with TS, including facial contortions, hyperextension of 
limbs, and co-contractions of opposing muscle groups82 as well as a similar age- 
dependent time course.83   Remarkably, the dtsz hamster also has a lower striatal volume, 
and a strikingly similar reduction in striatal PV+ interneuron number (41% decrease, 
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compared to 53% decrease in TS).84  These emerging lines of data strongly support a role 
for striatal PV+ interneuron deficit in TS and other hyperkinetic disorders.** 
The contribution of the GPe to movement disorders is only recently emerging. 
Microinjection studies in monkeys provide evidence for the involvement of projections 
from the ventral Cd to the GPe in tic-like stereotypies.86, 87  Connections between 
sensorimotor putamen, the GPe and the GPi appear to be involved in monkey models of 
dyskinesias,87 and PV+ GPe cells may be specifically involved in the sensorimotor 
pathway.88  The GPe receives projections from the striatal MSNs as part of the indirect 
pathway, and a reduction in cell number may represent a defect within this pathway, 
possibly allowing increased direct pathway activity, resulting in hyperkinesis.  However, 
within the classic rate model of the BG, loss of GPe neural projections to the STN would 
result in disinhibition of the GPi, and thus, decreased thalamic activity, and thus, a 
hypokinetic state.  As such, concordance with the rate model would require additional 
defects within the STN, or hyperactivity of the reduced number of GPe cells.  Further, the 
GPe sends direct projections to all other nuclei of the basal ganglia, including projections 
to the striatum,89  as well as the thalamus, and it appears to serve as a pacemaker of the 
basal ganglia.90  Hence the overall 46% decrease in total neuron number in the GPe in 
our cohort of severe cases of TS may implicate a change in overall BG oscillatory activity.  
Because the GPi is a major output of the basal ganglia and prominently involved in 
processing sensorimotor information, alterations of its structure are likely to figure 
                                                 
** It should be noted that, like our study, these studies did not assess other interneurons. Our 
emerging data suggests an additional decrease in a population of CR+ neurons, likely ACh 
neurons. Recent data shows a deficit in CR+ interneurons in this hamster model as well85.
 Hamann M, Sander SE, Richter A. Age-dependent alterations of striatal calretinin 
interneuron density in a genetic animal model of primary paroxysmal dystonia. J Neuropathol 
Exp Neurol 2005; 64:776-81.. 
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centrally in kinetic disorder pathophysiology.  The striking changes in the GPi do not 
easily fit with rate models of the basal ganglia.  An increase in GPi projection neurons, if 
all of them appropriately synapse within the thalamus, should inhibit thalamic activity, 
militating against hyperkinetic states.  One possible explanation would be that these cells 
represent a compensatory mechanism in TS.  However, such a theory has little support in 
the literature, relying on unknown mechanisms of significant neurogenesis.  The 
presence of these cells with the rate model seems best explained by assuming they are 
dys- or non-functional, either a by-product of a compensatory or pathologic process. 
Oscillatory models of BG function are more accommodating to alteration in GPi cell 
number.  Recent models of basal ganglia function have suggested that altered patterns of 
GPi discharge might be important in movement disorders.91  Recordings from the GPi 
analogue in the dtsz hamster reveal stunningly aberrant firing patterns which decrease as 
the hamster ages and the symptoms disappear.92  That the natural history of stereotypy 
within these hamsters and the natural history of the aberrant firing appear to mimic the 
natural history of TS is intriguing.  Similarly irregular firing patterns have also been 
recorded in the GPi of humans either with severe dystonia or severe TS.93  While it is 
possible that these firing patterns may be a downstream effect of striatal abnormalities in 
these conditions, they highlight the possible significance of an intrinsic GPi defect. 
Moreoever, some evidence suggests that placement of deep brain stimulation in the GPi, 
rather than the parafascicular or centromedian nuclei of the thalamus, may provide equal 
or superior control of tics.35, 42, 43  An increase of over 100% of PV+ GPi neurons in TS 
may very well generate aberrant firing patterns, which in turn may elicit secondary 
effects at thalamic level.  For example, excessive inhibitory input may provoke rebound 
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excitation in thalamic relay nuclei or alter the pace of their oscillatory activity.94  Such 
phenomena might result in the premonitory sensory  ‘urges’ so characteristic of TS. 
The post-hoc analysis to more precisely localize neuronal abnormalities provides 
further grounds for future studies.  Different CTSC pathways may also be differently 
susceptible to parvalbumin defects.  While the sensorimotor channel appears to operate 
in the beta band of oscillations, the limbic pathway (assessed from recordings in the 
hippocampus and ventral striatum) appears to operate at a theta frequency.20  A slower 
baseline frequency may be differentially sensitive to parvalbumin insults, or may reflect a 
lack of intrinsic PV+ activity.  The rostral and caudal sections used to re-analyze the GP 
roughly constitute, respectively, the associative circuit from the sensorimotor circuit.95 
The Pt caudally is involved in the sensorimotor circuit, while the rostral Pt, together with 
the Cd, approximates the striatal portion of the associative circuit.13  The GPi and Pt 
anomalies appear most severe within the sensorimotor areas, which fits well with the 
finding that poor performance on motor tasks in childhood predicts future tic severity.6 
Additionally, striatal PV+ interneurons receive both sensory and motor input from the 
cortex,96 and may play a role in integrating this information; some of TS phenomena may 
be explained by a decoupling of sensory and motor input.  The association areas of CTSC 
circuitry has defects in the striatum, GPi and perhaps also the GPe. The possibility that 
different CTSC circuits within the BG may be differently affected may help explain the 
phenotypic variety of TS, and perhaps wider neuropsychiatric disease.  However, this 
data would have to be reproduced in a specific study to analyze different circuits within 
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the BG, which our study was not designed to do.  Such data may further elucidate the 
neurobiology of TS.††  
Because of the various important roles of the PV+ neurons in the basal ganglia, these 
major changes in PV+ neuron distribution can be expected to have a dramatic effect in 
CSTC functioning, and may suggest possible etiologies for TS.  Increased investigation in 
interactions between dopamine and PV+ interneurons may be beneficial.97  Given the 
variety of both severity and longevity of TS, TS may represent several different etiologies 
which result in variable parvalbumin-positive interneuron alterations.  TS may have 
separate genetic or environmental causes, or may require varied combinations of each. 
The alterations demonstrated here, if related to TS etiology, would suggest problems in 
PV neuron development. Consistent with an altered distribution in the absence of major 
changes in number of PV cells would be a defect in PV+ cell migration, though problems 
in neurogenesis are possible as well.  
PV+ interneurons tangentially migrate from the medial ganglionic eminence (MGE), 
the precursor of the GP, to the LGE, the precursor to the striatum, as well as to the 
cerebral cortex and hippocampus; in humans, this occurs between 24 weeks of 
gestational age through 1 month post-partum.98 Embryonically, PV+ interneurons cells 
appear to preferentially receive cortical input, and are active during the formation of 
cortic0striatal synapses, suggesting a role in appropriate striatal development99; thus, 
besides from the disruption in function directly from the altered distribution of these 
cells, striatal development may be additionally hampered. 
                                                 
†† YK has done some preliminary work looking at anterior-posterior distinctions, confirming the 
rostral location of Pt PV+ deficiencies, and discovering that ACh interneurons may be 
preferentially depleted in the Cd head. 
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Environmental insults may not only damage PV+ cells during their perinatal 
migration.  PV+ neurons appear susceptible to excitotoxic injury100, 101 as well as being 
particularly vulnerable to ischemic insults.102  Studies focusing on perinatal hypoxia, a 
known risk factor for TS, and PV+ striatal interneurons may be promising.  Perinatal 
asphyxia in rats, for example, produces a substantial decrease in striatal PV+ 
interneurons as well as motor dyscoordination.103 
 Genetic causes may also play a role.  The Nkx2.1 gene, which is necessary for the 
specification of the MGE, is also required for the specification of these interneurons of 
the striatum, while the Dlx1/Dlx2 genes are required for their migration.104, 105  Thus, a 
possible explanation for our data is that abnormalities in these or related genes during 
development cause altered migration of neurons arising from the MGE in TS patients.  It 
is interesting to note that haploinsufficiency for Nkx2.1 has been associated with a mild 
form of dyskinesia and chorea in humans.106, 107  
The observations presented here demonstrate significant alterations in the PV neuron 
populations of the BG in TS.  These findings appear to bolster current theories of TS 
pathophysiology and etiology, and, it is hoped, will open a new front of investigation in 
TS.  These findings provide ammunition for hypothesis generation, which will need 
experimental testing.  Development of a mouse model where PV+ neurons may be 
selectively lesioned would be of a great utility, and work on such a model is set to begin at 
Yale.   
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Figure 8. Distribution of PV+ cells throughout the striatum and globus pallidus. 
The location of PV+ cells differed between TS and control, with TS brains possessing a 
much larger proportion in the GPi, and far fewer in the striatum. No difference in total 
number was noted, though small sample size could explain this.  
 
 
 
 
Figure 9. The migratory path of 
parvalbumin-positive cells. 
 
During development, parvalbumin-
positive cells originate in the medial 
ganglionic eminence (MGE), which 
itself develops into the globus 
pallidus.  Cells migrate from the 
MGE to the lateral ganglionic 
eminence (LGE).  The LGE develops 
into the striatum.  The distribution of 
parvalbumin-positive cells described 
above is thus consistent with a defect 
in migration of this cell population. 
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Ultimately, our data serves both to highlight an important circuit in TS pathology as 
well as an underutilized research methodology in neuropsychiatric diseases.  Our 
research suggests the importance of the ACh-PV-MSN striatal circuit, as well as directing 
further research towards the GPi.  The importance of clarifying the neural circuitry of TS 
remains important not only for understanding it and related diseases, but for developing 
treatments.  In severe cases of TS, deep brain stimulation electrodes are positioned to 
affect the circuitry discussed here; clarifying the activity of this circuitry may help 
optimize treatment.  Moreover, our work demonstrates the fruitfulness of quantitative 
immunohistochemistry in investigating neuropsychiatric disease.  Since the publication 
of our data64 and an accompanying paper on PV+ cells and oscillatory frequencies,50 
other studies have been produced highlighting the importance of gamma oscillations and 
deficiencies of other PV+  networks in other neuropsychiatric diseases.108, 109  Defects in 
PV+ interneuron networks may play a significant role in explaining neuropsychiatric 
disease. The contributions of our work, we hope, are three-fold: a robust defense of 
stereologic techniques in exploring neuropsychiatric disease; the first quantitative 
pathological demonstration of a neural defect in TS; and the first discovery of the link 
between the PV+ interneuron network and human neuropsychiatric disease.  
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